News

bit.bio founder and CEO Dr Mark Kotter has 15 minutes to explain how we program biology as software to develop affordable next gen...

New advisors will provide important and independent guidance.

Products aim to address the translation gap and accelerate research and drug discovery for neurodegenerative disease.

bit.bio received a bronze award for its participation in the Green Impact awards for sustainability.

bit.bio’s Founder and CEO Dr Mark Kotter on creating every cell type and kickstarting a cell therapy revolution.

bit.bio is supporting the iGEM team from University of Cambridge in the iGEM synbio competition.

In this Financial Times piece our CEO is reflecting on raising concerns about the lab spaces for rent within science clusters. 

This piece covers how bit.bio's technology is also used by Meatable for their cultured meat products.